Viewing Study NCT02559856


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-30 @ 1:19 AM
Study NCT ID: NCT02559856
Status: COMPLETED
Last Update Posted: 2025-11-17
First Post: 2015-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Bleeding Risk Between Rivaroxaban and Apixaban: The Pilot Study
Sponsor: Ottawa Hospital Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module